Martingale Asset Management’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-75,622
| Closed | -$338K | – | 908 |
|
|
2022
Q2 | $338K | Buy |
75,622
+10
| +0% | +$45 | 0.01% | 721 |
|
|
2022
Q1 | $381K | Buy |
75,612
+12,412
| +20% | +$62.5K | 0.01% | 688 |
|
|
2021
Q4 | $551K | Buy |
63,200
+313
| +0.5% | +$2.73K | 0.01% | 629 |
|
|
2021
Q3 | $587K | Buy |
62,887
+42,461
| +208% | +$396K | 0.01% | 634 |
|
|
2021
Q2 | $262K | Buy |
+20,426
| New | +$262K | ﹤0.01% | 743 |
|